Does Rallies track congressional trades in TECH?

Yes. Rallies tracks politician and congressional stock disclosures for TECH, including reported purchases, sales, dates, owners, and trade amounts when available.

Is TECH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for TECH. It does not provide personalized investment advice.

TECH (Bio-Techne Corp.) Stock Analysis - Politician Trades

Bio-Techne Corp. (TECH) is a publicly traded Healthcare sector company. As of May 20, 2026, TECH trades at $46.69 with a market cap of $6.96B and a P/E ratio of 64.94. TECH moved +2.74% today. Year to date, TECH is -25.91%; over the trailing twelve months it is -5.71%. Its 52-week range spans $43.20 to $80.80. Analyst consensus is buy with an average price target of $59.25. Rallies surfaces TECH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded TECH stock?

Recent politician trading activity in TECH includes disclosures from April Delaney, April Delaney, April Delaney, April Delaney, and April Delaney. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

TECH Key Metrics

Key financial metrics for TECH
Metric	Value
Price	$46.69
Market Cap	$6.96B
P/E Ratio	64.94
EPS	$0.71
Dividend Yield	0.08%
52-Week High	$80.80
52-Week Low	$43.20
Volume	2.26M
Avg Volume	0
Revenue (TTM)	$1.21B
Net Income	$109.56M
Gross Margin	64.96%

Congressional Trades in TECH

April Delaney sale TECH on Feb 24, 2026 (amount: $15.00K).
April Delaney sale TECH on Jan 28, 2026 (amount: $15.00K).
April Delaney purchase TECH on Dec 5, 2025 (amount: $15.00K).
April Delaney purchase TECH on Dec 2, 2025 (amount: $15.00K).
April Delaney purchase TECH on Oct 22, 2025 (amount: $15.00K).

Latest TECH News

Bio-Techne sinks as fiscal Q3 revenue misses on weaker academic demand — May 6, 2026
Bio-Techne Q3 Revenue Dips to $311.4M, EPS Mixed, Declares $0.08 Dividend — May 6, 2026
Bio-Techne climbs as investors position ahead of May 6 fiscal Q3 earnings — May 5, 2026
Bio-Techne jumps ahead of May 6 earnings as analysts refocus on outlook — Apr 30, 2026
Bio-Techne slides as traders de-risk ahead of May 6 earnings report — Apr 29, 2026

Recent TECH Insider Trades

Herr Amy E. sold 1.98K (~$116.79K) on Feb 17, 2026.
Nusse Roeland sold 17.04K (~$960.39K) on Aug 25, 2025.
BAUMGARTNER ROBERT V sold 17.04K (~$957.82K) on Aug 25, 2025.

TECH Analyst Consensus

10 analysts cover TECH: 0 strong buy, 6 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $59.25.

Common questions about TECH

Which politicians traded TECH stock?: Recent politician trading activity in TECH includes disclosures from April Delaney, April Delaney, April Delaney, April Delaney, and April Delaney. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in TECH?: Yes. Rallies tracks politician and congressional stock disclosures for TECH, including reported purchases, sales, dates, owners, and trade amounts when available.
Is TECH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for TECH. It does not provide personalized investment advice.